Selected research
Industry Research
Proteinase K Solution Industry Research Report 2026
Market perspective
The global Proteinase K Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Proteinase K Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Proteinase K Solution is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Proteinase K Solution is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Proteinase K Solution include Azura Genomics, BBI, Biosharp, Bioswisstec, Canvax Biotech, Geneilabs, ITW Reagents, Lucigen Corporation and Magen Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Proteinase K Solution market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Proteinase K Solution Market by Company
Azura Genomics
BBI
Biosharp
Bioswisstec
Canvax Biotech
Geneilabs
ITW Reagents
Lucigen Corporation
Magen Biotechnology
Merck
Meridian Bioscience
Norgen Biotek
Promega Corporation
STEMCELL Technologies
Thermo Fisher
Mei5 Biotechnology
Life-iLab
TIANGEN BIOTECH
Proteinase K Solution Segment by Type
20 mg/mL Solution
10 mg/mL Solution
Others
Proteinase K Solution Segment by Application
Biotechnology
Academic Institutions
Others
Proteinase K Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Proteinase K Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Proteinase K Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Proteinase K Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Proteinase K Solution manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Proteinase K Solution by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Proteinase K Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20 mg/mL Solution
- 10 mg/mL Solution
- Others
Applications
- Biotechnology
- Academic Institutions
- Others
Companies covered
- Azura Genomics
- BBI
- Biosharp
- Bioswisstec
- Canvax Biotech
- Geneilabs
- ITW Reagents
- Lucigen Corporation
- Magen Biotechnology
- Merck
- Meridian Bioscience
- Norgen Biotek
- Promega Corporation
- STEMCELL Technologies
- Thermo Fisher
- Mei5 Biotechnology
- Life-iLab
- TIANGEN BIOTECH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Proteinase K Solution Market Size (2021-2032)
- 2.2.2 Global Proteinase K Solution Sales (2021-2032)
- 2.2.3 Global Proteinase K Solution Market Average Price (2021-2032)
- 2.3 Proteinase K Solution by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 20 mg/mL Solution
- 2.3.3 10 mg/mL Solution
- 2.3.4 Others
- 2.4 Proteinase K Solution by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Biotechnology
- 2.4.3 Academic Institutions
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Proteinase K Solution Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Proteinase K Solution Sales (L) of Manufacturers (2021-2026)
- 3.3 Global Proteinase K Solution Revenue of Manufacturers (2021-2026)
- 3.4 Global Proteinase K Solution Average Price by Manufacturers (2021-2026)
- 3.5 Global Proteinase K Solution Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Proteinase K Solution, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Proteinase K Solution, Product Type & Application
- 3.8 Global Manufacturers of Proteinase K Solution, Established Date
- 3.9 Global Proteinase K Solution Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Azura Genomics
- 4.1.1 Azura Genomics Company Information
- 4.1.2 Azura Genomics Business Overview
- 4.1.3 Azura Genomics Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Azura Genomics Proteinase K Solution Product Portfolio
- 4.1.5 Azura Genomics Recent Developments
- 4.2 BBI
- 4.2.1 BBI Company Information
- 4.2.2 BBI Business Overview
- 4.2.3 BBI Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BBI Proteinase K Solution Product Portfolio
- 4.2.5 BBI Recent Developments
- 4.3 Biosharp
- 4.3.1 Biosharp Company Information
- 4.3.2 Biosharp Business Overview
- 4.3.3 Biosharp Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Biosharp Proteinase K Solution Product Portfolio
- 4.3.5 Biosharp Recent Developments
- 4.4 Bioswisstec
- 4.4.1 Bioswisstec Company Information
- 4.4.2 Bioswisstec Business Overview
- 4.4.3 Bioswisstec Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bioswisstec Proteinase K Solution Product Portfolio
- 4.4.5 Bioswisstec Recent Developments
- 4.5 Canvax Biotech
- 4.5.1 Canvax Biotech Company Information
- 4.5.2 Canvax Biotech Business Overview
- 4.5.3 Canvax Biotech Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Canvax Biotech Proteinase K Solution Product Portfolio
- 4.5.5 Canvax Biotech Recent Developments
- 4.6 Geneilabs
- 4.6.1 Geneilabs Company Information
- 4.6.2 Geneilabs Business Overview
- 4.6.3 Geneilabs Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Geneilabs Proteinase K Solution Product Portfolio
- 4.6.5 Geneilabs Recent Developments
- 4.7 ITW Reagents
- 4.7.1 ITW Reagents Company Information
- 4.7.2 ITW Reagents Business Overview
- 4.7.3 ITW Reagents Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ITW Reagents Proteinase K Solution Product Portfolio
- 4.7.5 ITW Reagents Recent Developments
- 4.8 Lucigen Corporation
- 4.8.1 Lucigen Corporation Company Information
- 4.8.2 Lucigen Corporation Business Overview
- 4.8.3 Lucigen Corporation Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lucigen Corporation Proteinase K Solution Product Portfolio
- 4.8.5 Lucigen Corporation Recent Developments
- 4.9 Magen Biotechnology
- 4.9.1 Magen Biotechnology Company Information
- 4.9.2 Magen Biotechnology Business Overview
- 4.9.3 Magen Biotechnology Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Magen Biotechnology Proteinase K Solution Product Portfolio
- 4.9.5 Magen Biotechnology Recent Developments
- 4.10 Merck
- 4.10.1 Merck Company Information
- 4.10.2 Merck Business Overview
- 4.10.3 Merck Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Merck Proteinase K Solution Product Portfolio
- 4.10.5 Merck Recent Developments
- 4.11 Meridian Bioscience
- 4.11.1 Meridian Bioscience Company Information
- 4.11.2 Meridian Bioscience Business Overview
- 4.11.3 Meridian Bioscience Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Meridian Bioscience Proteinase K Solution Product Portfolio
- 4.11.5 Meridian Bioscience Recent Developments
- 4.12 Norgen Biotek
- 4.12.1 Norgen Biotek Company Information
- 4.12.2 Norgen Biotek Business Overview
- 4.12.3 Norgen Biotek Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Norgen Biotek Proteinase K Solution Product Portfolio
- 4.12.5 Norgen Biotek Recent Developments
- 4.13 Promega Corporation
- 4.13.1 Promega Corporation Company Information
- 4.13.2 Promega Corporation Business Overview
- 4.13.3 Promega Corporation Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Promega Corporation Proteinase K Solution Product Portfolio
- 4.13.5 Promega Corporation Recent Developments
- 4.14 STEMCELL Technologies
- 4.14.1 STEMCELL Technologies Company Information
- 4.14.2 STEMCELL Technologies Business Overview
- 4.14.3 STEMCELL Technologies Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 STEMCELL Technologies Proteinase K Solution Product Portfolio
- 4.14.5 STEMCELL Technologies Recent Developments
- 4.15 Thermo Fisher
- 4.15.1 Thermo Fisher Company Information
- 4.15.2 Thermo Fisher Business Overview
- 4.15.3 Thermo Fisher Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Thermo Fisher Proteinase K Solution Product Portfolio
- 4.15.5 Thermo Fisher Recent Developments
- 4.16 Mei5 Biotechnology
- 4.16.1 Mei5 Biotechnology Company Information
- 4.16.2 Mei5 Biotechnology Business Overview
- 4.16.3 Mei5 Biotechnology Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Mei5 Biotechnology Proteinase K Solution Product Portfolio
- 4.16.5 Mei5 Biotechnology Recent Developments
- 4.17 Life-iLab
- 4.17.1 Life-iLab Company Information
- 4.17.2 Life-iLab Business Overview
- 4.17.3 Life-iLab Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Life-iLab Proteinase K Solution Product Portfolio
- 4.17.5 Life-iLab Recent Developments
- 4.18 TIANGEN BIOTECH
- 4.18.1 TIANGEN BIOTECH Company Information
- 4.18.2 TIANGEN BIOTECH Business Overview
- 4.18.3 TIANGEN BIOTECH Proteinase K Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 TIANGEN BIOTECH Proteinase K Solution Product Portfolio
- 4.18.5 TIANGEN BIOTECH Recent Developments
5 Global Proteinase K Solution Market Scenario by Region
- 5.1 Global Proteinase K Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Proteinase K Solution Sales by Region: 2021-2032
- 5.2.1 Global Proteinase K Solution Sales by Region: 2021-2026
- 5.2.2 Global Proteinase K Solution Sales by Region: 2027-2032
- 5.3 Global Proteinase K Solution Revenue by Region: 2021-2032
- 5.3.1 Global Proteinase K Solution Revenue by Region: 2021-2026
- 5.3.2 Global Proteinase K Solution Revenue by Region: 2027-2032
- 5.4 North America Proteinase K Solution Market Facts & Figures by Country
- 5.4.1 North America Proteinase K Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Proteinase K Solution Sales by Country (2021-2032)
- 5.4.3 North America Proteinase K Solution Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Proteinase K Solution Market Facts & Figures by Country
- 5.5.1 Europe Proteinase K Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Proteinase K Solution Sales by Country (2021-2032)
- 5.5.3 Europe Proteinase K Solution Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Proteinase K Solution Market Facts & Figures by Country
- 5.6.1 Asia Pacific Proteinase K Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Proteinase K Solution Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Proteinase K Solution Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Proteinase K Solution Market Facts & Figures by Country
- 5.7.1 South America Proteinase K Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Proteinase K Solution Sales by Country (2021-2032)
- 5.7.3 South America Proteinase K Solution Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Proteinase K Solution Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Proteinase K Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Proteinase K Solution Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Proteinase K Solution Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Proteinase K Solution Sales by Type (2021-2032)
- 6.1.1 Global Proteinase K Solution Sales by Type (2021-2032) & (L)
- 6.1.2 Global Proteinase K Solution Sales Market Share by Type (2021-2032)
- 6.2 Global Proteinase K Solution Revenue by Type (2021-2032)
- 6.2.1 Global Proteinase K Solution Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Proteinase K Solution Revenue Market Share by Type (2021-2032)
- 6.3 Global Proteinase K Solution Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Proteinase K Solution Sales by Application (2021-2032)
- 7.1.1 Global Proteinase K Solution Sales by Application (2021-2032) & (L)
- 7.1.2 Global Proteinase K Solution Sales Market Share by Application (2021-2032)
- 7.2 Global Proteinase K Solution Revenue by Application (2021-2032)
- 7.2.1 Global Proteinase K Solution Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Proteinase K Solution Revenue Market Share by Application (2021-2032)
- 7.3 Global Proteinase K Solution Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Proteinase K Solution Value Chain Analysis
- 8.1.1 Proteinase K Solution Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Proteinase K Solution Production Mode & Process
- 8.2 Proteinase K Solution Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Proteinase K Solution Distributors
- 8.2.3 Proteinase K Solution Customers
9 Global Proteinase K Solution Analyzing Market Dynamics
- 9.1 Proteinase K Solution Industry Trends
- 9.2 Proteinase K Solution Industry Drivers
- 9.3 Proteinase K Solution Industry Opportunities and Challenges
- 9.4 Proteinase K Solution Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst